Skip to main content
Article
The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory response.
Journal for ImmunoTherapy of Cancer (2020)
  • Fernanda I Arnaldez, MacroGenics Inc
  • Steven J O'Day, John Wayne Cancer Institute and Cancer Clinic, Providence Saint John's Health Center, Santa Monica, California, United States.
  • Charles G Drake, Columbia University Medical Center
  • Bernard A Fox, Earle A Chiles Research Institute, Portland, Oregon, USA.
  • Bingqing Fu, University of Science and Technology of China
  • Walter J Urba, Earle A Chiles Research Institute, Portland, Oregon, USA.
  • Vincenzo Montesarchio, A.O.R.N. dei Colli Monaldi-Cotugno-CTO Hospitals, Naples, Italy.
  • Jeffrey S Weber, Perlmutter Cancer Center, NYU Langone Health, New York, New York, USA.
  • Haiming Wei, University of Science and Technology of China
  • Jon M Wigginton, Frederick, Maryland, USA.
  • Paolo Antonio Ascierto, Istituto Nazionale Tumori IRCCS Fondazione 'G. Pascale', Napels, Italy paolo.ascierto@gmail.com.
Publication Date
May 1, 2020
DOI
10.1136/JITC-2020-000930
Citation Information
Fernanda I Arnaldez, Steven J O'Day, Charles G Drake, Bernard A Fox, et al.. "The Society for Immunotherapy of Cancer perspective on regulation of interleukin-6 signaling in COVID-19-related systemic inflammatory response." Journal for ImmunoTherapy of Cancer Vol. 8 Iss. 1 (2020)
Available at: http://works.bepress.com/walter-urba/283/